ORR and CR rate with CDP therapy
| . | Number . | ORR (95% CI) . | CR rate (95% CI) . |
|---|---|---|---|
| All patients | 52 | 94% (84-99) | 50% (36-64) |
| Patients with ≥5 lines of prior therapy | 30 | 90% (73-98) | 47% (28-66) |
| Patients with previous ASCT | 12 | 100% (74-100) | 58% (28-85) |
| Transplant-ineligible patients | 40 | 93% (80-98) | 48% (32-64) |
| Patients with previous DP therapy | |||
| CR/PR after DP therapy | 40 | 93% (80-98) | 58% (41-73) |
| SD/PD after DP therapy | 12 | 100% (74-100) | 25% (5-57) |
| . | Number . | ORR (95% CI) . | CR rate (95% CI) . |
|---|---|---|---|
| All patients | 52 | 94% (84-99) | 50% (36-64) |
| Patients with ≥5 lines of prior therapy | 30 | 90% (73-98) | 47% (28-66) |
| Patients with previous ASCT | 12 | 100% (74-100) | 58% (28-85) |
| Transplant-ineligible patients | 40 | 93% (80-98) | 48% (32-64) |
| Patients with previous DP therapy | |||
| CR/PR after DP therapy | 40 | 93% (80-98) | 58% (41-73) |
| SD/PD after DP therapy | 12 | 100% (74-100) | 25% (5-57) |